Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBOVER study of intravitreal bevacizumab for macular edema due to retinal vein occlusion
2008-005789-30Phase 3Completed
- Sponsor
- IOBA
- Start
- Feb 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab in Vein occlusion (RVO) (2 arms), sponsored by IOBA. Primary endpoints: Best corrected visual acuity, Change in central visual acuity and 1 more. Started Feb 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
Vein occlusion (RVO)
Beyond the preview
Go deeper on 2008-005789-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005789-30.